01 · CONNECTED KNOWLEDGE
Biotech Knowledge Graph
Connects companies, assets, trials, endpoints, regulatory events and source evidence in one retrievable knowledge structure.
Real-time biotech intelligence From monitoring to analysis
As a multi-agent AI platform, we transform primary disclosures and clinical trial results into evidence-based analytical report for investors within 5 min, during the most critical trading window.
FEATURED EVENT ANALYSIS
See the Intelligence In Practice
Featured report 1 of 4: MYQORZO FDA Approval.
WHY BIOTECHANALYZER
Fast + Deep + Auditable
Headline News
- Mostly copies company news releases
- Vague and shallow
- Highly homogenized coverage
- Could potentially be misleading
Traditional Research
- Days to produce—trading window missed
- Labor-intensive
- Limited by human capacity in terms of comprehensiveness and speed
- Unstable availability of analysis
BiotechAnalyzer
- 24/7 real-time monitoring of 650+ U.S.-listed biotech and pharmaceutical companies
- In-depth analysis for every target event type delivered within five minutes
- Biotech Knowledge Graph
- Chain of Thoughts (CoT)
- Publication-Ready Intelligence
- Disclosure Language Analysis
- Trading-Background Context
EVIDENCE ARCHITECTURE
Understand, Connect and Analyze Like an Expert
A connected knowledge layer organizes biotech evidence; a structured reasoning system turns those relationships into traceable analysis.
02 · STRUCTURED REASONING
Chain of Thought (CoT)
A disciplined analytical framework designed to interpret complex information, identify meaningful relationships and reveal the insights that matter.
BUILT FOR PROFESSIONAL USE
Three Additional Safeguards
01 · LEGAL-RISK AWARE
Publication-Ready Intelligence
Purpose-built article structures avoid investment-advice language and misleading claims that could create legal risk. Every factual statement is source-backed and verified for factual accuracy.
- Investment-advice language avoided
- Misleading-claim and legal-risk checks
- Source-backed factual verification
02 · LANGUAGE CONTROL
Disclosure Language Analysis
A dedicated linguistic evaluator scans each original trigger news release, detecting and red-flagging ambiguous wording, conflated concepts and other language that could materially distort interpretation of the event.
- Original-release language screening
- Ambiguous wording and concept-confusion flags
- Material interpretation-risk alerts
03 · MARKET CONTEXT
Trading-Background Context
Event analysis is framed through catalyst expectations, timing, surprise and market mechanism to explain not only what happened, but also why it may matter.
- Pre-event expectation context
- Catalyst direction and confidence
- Timing and market-window awareness
THE BIOTECHANALYZER ADVANTAGE
A repeatable intelligence layer for critical biotech catalysts
Evidence Framework
- Evidence-linked material claims
- Source-to-analysis traceability
- Eight event-specific frameworks
- Standardized biotech taxonomy
Market Intelligence
- 24/7 real-time monitoring
- Trading-aware event context
- Cross-company market context
- Structured catalyst tracking
Professional Delivery
- Five-minute target turnaround
- Legal-risk-aware article design
- Brokerage and newsroom ready
BiotechAnalyzer covers 650+ US listed
Pharmaceutical & Biotech companies 24/7
BayerAstraZenecaIpsenAlkermesUroGenTakedaSummitAstraZenecaAlnylamGileadNovartisBiogenCSLRegeneronBioMarinModernaIncytesanofi
Novo
NordiskargenxUnited
TherapeuticsNeurocrineInsmedTevaBeOneHalozymeExelixisJazzViatrisBioNTech
NordiskargenxUnited
TherapeuticsNeurocrineInsmedTevaBeOneHalozymeExelixisJazzViatrisBioNTech